Form 4: Danaher Corp SVP, Human Resources, Receives Stock Options and Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Georgeann Couchara, SVP of Human Resources at Danaher Corp, reports the acquisition of stock options and restricted stock units (RSUs) on March 1, 2024.

Summary

  • On March 1, 2024, Georgeann Couchara, SVP of Human Resources at Danaher Corp, was granted 1,466 restricted stock units (RSUs).
  • These RSUs vest in equal installments over four years, starting March 1, 2024.
  • Couchara also received employee stock options to purchase 11,632 shares at an exercise price of $255.87, with half vesting on each of the third and fourth anniversaries of the grant date.
  • Additionally, Couchara received employee stock options to purchase 3,490 shares at an exercise price of $255.87, with one fourth vesting on each of the first four anniversaries of the grant date.
  • Following these transactions, Couchara directly owns 5,445 shares of Danaher Corp common stock, 11,632 employee stock options (right to buy), and 3,490 employee stock options (right to buy).

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The document reflects standard executive compensation practices, which are generally viewed favorably as they align management interests with shareholder value. There are no indications of negative performance or concerns.

Positives

  • The grant of RSUs and stock options to a key executive like the SVP of Human Resources suggests the company's commitment to aligning management's interests with those of shareholders.
  • The vesting schedules of the RSUs and stock options incentivize the executive to remain with the company and contribute to its long-term success.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedules of the RSUs and stock options suggest a multi-year commitment from the executive.

Industry Context

Stock option and RSU grants are common practices in executive compensation, particularly in large corporations like Danaher, to incentivize performance and align executive interests with shareholder value.

Comparison to Industry Standards

  • Danaher's executive compensation practices, including the use of stock options and RSUs, are generally in line with industry standards for large, publicly traded companies.
  • Companies like Thermo Fisher Scientific, Abbott Laboratories, and Siemens also utilize similar equity-based compensation strategies to incentivize their executives.
  • The vesting schedules and exercise prices are typical for such grants, designed to reward long-term value creation.

Stakeholder Impact

  • Shareholders may view the equity grants positively as they align executive interests with long-term company performance.
  • Employees may see the grants as a sign of the company's commitment to its leadership team.

Key Dates

DateDescription
03/01/2024Date of earliest transaction: Grant date of RSUs and stock options.
03/01/2024Vesting start date for RSUs, with one-fourth vesting annually for four years.
03/01/2034Expiration date for employee stock options.
03/05/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.